Go Pro
NYSE:PACS

PACS Group (PACS) Stock Price, News & Analysis

PACS Group logo
$42.59 -0.50 (-1.16%)
As of 03:40 PM Eastern

About PACS Group Stock (NYSE:PACS)

Advanced

Key Stats

Today's Range
$42.07
$43.68
50-Day Range
$39.94
$48.61
52-Week Range
$7.50
$49.49
Volume
328,665 shs
Average Volume
910,268 shs
Market Capitalization
$6.74 billion
P/E Ratio
24.76
Dividend Yield
N/A
Price Target
$56.00
Consensus Rating
Buy

Company Overview

PACS Group, Inc., through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. The company also provides senior care and independent facilities. It engages in the acquisition, ownership, and leasing of health care-related properties. The company was founded in 2013 and is based in Farmington, Utah.

PACS Group Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
92nd Percentile Overall Score

PACS MarketRank™: 

PACS Group scored higher than 92% of companies evaluated by MarketBeat, and ranked 45th out of 914 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    PACS Group has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 strong buy rating, 5 buy ratings, 1 hold rating, and no sell ratings.

  • Upside Potential

    PACS Group has a consensus price target of $56.00, representing about 33.1% upside from its current price of $42.07.

  • Amount of Analyst Coverage

    PACS Group has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about PACS Group's stock forecast and price target.
  • Earnings Growth

    Earnings for PACS Group are expected to grow by 7.63% in the coming year, from $2.36 to $2.54 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of PACS Group is 24.46, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 39.18.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of PACS Group is 24.46, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 273.79.

  • Price to Earnings Growth Ratio

    PACS Group has a PEG Ratio of 1.19. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    PACS Group has a P/B Ratio of 5.97. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about PACS Group's valuation and earnings.
  • Percentage of Shares Shorted

    7.57% of the float of PACS Group has been sold short.
  • Short Interest Ratio / Days to Cover

    PACS Group has a short interest ratio ("days to cover") of 3.57, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in PACS Group has recently decreased by 6.24%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    PACS Group does not currently pay a dividend.

  • Dividend Growth

    PACS Group does not have a long track record of dividend growth.

  • News Sentiment

    PACS Group has a news sentiment score of 0.37. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.79 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 5 news articles for PACS Group this week, compared to 4 articles on an average week.
  • Search Interest

    Only 12 people have searched for PACS on MarketBeat in the last 30 days. This is a decrease of -25% compared to the previous 30 days.
  • MarketBeat Follows

    10 people have added PACS Group to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, PACS Group insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $47,458,833.00 in company stock.

  • Percentage Held by Insiders

    70.10% of the stock of PACS Group is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    PACS Group has minimal institutional ownership at this time.

  • Read more about PACS Group's insider trading history.
Receive PACS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PACS Group and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

PACS Stock News Headlines

PACS' Florida Deal Supports Market Expansion, UBS Says
Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing.tc pixel
PACS Group To Acquire Operations Of 32 Florida Facilities
PACS Group (NYSE:PACS) CEO Sells 59,244 Shares
PACS Group (NYSE:PACS) CEO Sells 66,797 Shares
PACS Group logo beside a caregiver walking arm in arm with an elderly woman in a care facility hallway.
Amid Legal Risks, This Company Is Still Rated a Buy
PACS Group shares have rebounded after a Medicare billing scandal, with strong Q2 earnings and Buy ratings, though DOJ and SEC investigations and shareholder lawsuits remain unresolved.
See More Headlines

PACS Stock Analysis - Frequently Asked Questions

PACS Group's stock was trading at $38.28 at the beginning of the year. Since then, PACS stock has increased by 9.9% and is now trading at $42.0650.

PACS Group, Inc. (NYSE:PACS) released its quarterly earnings results on Tuesday, August, 4th. The company reported $0.63 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.54 by $0.09. The company earned $1.43 billion during the quarter, compared to analysts' expectations of $1.41 billion. PACS Group had a net margin of 4.85% and a trailing twelve-month return on equity of 29.55%.
Read the conference call transcript
.

PACS Group (PACS) raised $450 million in an initial public offering (IPO) on Thursday, April 11th 2024. The company issued 21,428,572 shares at a price of $20.00-$22.00 per share.

PACS Group's top institutional shareholders include California State Teachers Retirement System (1.21%), Wellington Management Group LLP (0.42%), Bank of New York Mellon Corp (0.12%) and Corient Private Wealth LP (0.10%). Insiders that own company stock include Jason Hulse Murray, Mark Hancock, Joshua Jergensen, John Todd Mitchell, Michelle Renee Lewis, Evelyn S Dilsaver and Jacqueline Millard.
View institutional ownership trends
.

Shares of PACS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that PACS Group investors own include NVIDIA (NVDA), Tesla (TSLA), Meta Platforms (META), Advanced Micro Devices (AMD), JPMorgan Chase & Co. (JPM), Netflix (NFLX) and Visa (V).

Company Calendar

Last Earnings
8/04/2026
Today
9/03/2026
Next Earnings (Estimated)
11/09/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Healthcare Providers & Services
Sub-Industry
Healthcare Facilities
Current Symbol
NYSE:PACS
Previous Symbol
NYSE:PACS
CIK
2001184
Fax
N/A
Employees
47,455
Year Founded
N/A

Price Target and Rating

High Price Target
$62.00
Low Price Target
$44.00
Potential Upside/Downside
+32.2%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
7 Analysts

Profitability

EPS (Trailing Twelve Months)
$1.72
Trailing P/E Ratio
24.63
Forward P/E Ratio
17.95
P/E Growth
1.19
Net Income
$191.54 million
Net Margins
4.85%
Pretax Margin
6.89%
Return on Equity
29.55%
Return on Assets
5.23%

Debt

Debt-to-Equity Ratio
0.21
Current Ratio
0.91
Quick Ratio
0.91

Sales & Book Value

Annual Sales
$5.29 billion
Price / Sales
1.27
Cash Flow
$1.61 per share
Price / Cash Flow
26.36
Book Value
$7.05 per share
Price / Book
6.01

Miscellaneous

Outstanding Shares
158,270,000
Free Float
47,323,000
Market Cap
$6.71 billion
Optionable
Optionable
Beta
-0.13
7 Stocks That Will Be Magnificent in 2026 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NYSE:PACS) was last updated on 9/3/2026 by MarketBeat.com Staff.
From Our Partners